170 related articles for article (PubMed ID: 16611388)
1. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
Greyling A; De Witt C; Oosthuizen W; Jerling JC
Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
[TBL] [Abstract][Full Text] [Related]
2. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
3. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
[TBL] [Abstract][Full Text] [Related]
4. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
[TBL] [Abstract][Full Text] [Related]
6. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
[TBL] [Abstract][Full Text] [Related]
8. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
[TBL] [Abstract][Full Text] [Related]
9. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations.
Lin Y; Rudrum M; van der Wielen RP; Trautwein EA; McNeill G; Sierksma A; Meijer GW
Metabolism; 2004 Oct; 53(10):1309-14. PubMed ID: 15375787
[TBL] [Abstract][Full Text] [Related]
10. Effects of policosanol on postmenopausal women with type II hypercholesterolemia.
Castaño G; Más R; Fernández L; Fernández JC; Illnait J; López LE; Alvarez E
Gynecol Endocrinol; 2000 Jun; 14(3):187-95. PubMed ID: 10923280
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
Castaño G; Mas R; Fernández L; Illnait J; Mesa M; Alvarez E; Lezcay M
Drugs Aging; 2003; 20(2):153-63. PubMed ID: 12534315
[TBL] [Abstract][Full Text] [Related]
12. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial.
Dulin MF; Hatcher LF; Sasser HC; Barringer TA
Am J Clin Nutr; 2006 Dec; 84(6):1543-8. PubMed ID: 17158441
[TBL] [Abstract][Full Text] [Related]
13. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
Tedeschi-Reiner E; Reiner Z; Romić Z; Ivanković D
Lijec Vjesn; 2005; 127(11-12):273-9. PubMed ID: 16583932
[TBL] [Abstract][Full Text] [Related]
14. Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study.
Francini-Pesenti F; Brocadello F; Beltramolli D; Nardi M; Caregaro L
Complement Ther Med; 2008 Apr; 16(2):61-5. PubMed ID: 18514906
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypercholesterolemia in NIDDM with policosanol.
Torres O; Agramonte AJ; Illnait J; Más Ferreiro R; Fernández L; Fernández JC
Diabetes Care; 1995 Mar; 18(3):393-7. PubMed ID: 7555484
[TBL] [Abstract][Full Text] [Related]
16. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
Castaño G; Más R; Fernández JC; Illnait J; Fernández L; Alvarez E
J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M186-92. PubMed ID: 11253161
[TBL] [Abstract][Full Text] [Related]
17. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
Pons P; Rodríguez M; Robaina C; Illnait J; Más R; Fernández L; Fernández JC
Int J Clin Pharmacol Res; 1994; 14(1):27-33. PubMed ID: 7927958
[TBL] [Abstract][Full Text] [Related]
18. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
19. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
Prat H; Román O; Pino E
Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
[TBL] [Abstract][Full Text] [Related]
20. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.
Castaño G; Más R; Fernández JC; Fernández L; Illnait J; López E
Drugs R D; 2002; 3(3):159-72. PubMed ID: 12099160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
